Joseph Ravenell

Joseph Ravenell, MD, MS, is Assistant Professor of Population Health and Medicine at NYU School of Medicine. He is a core member of the Center for Healthful Behavior Change, a board-certified internist and hypertension specialist with a strong track record of NIH funding to improve cardiovascular disease in diverse populations. He is Principle Investigator (PI) or co-PI of 3 community-based randomized trials: 1) a National Heart, Lung, Blood Institute R01 (1R01HL096946) grant to test community-based strategies to improve blood pressure control and colon cancer screening in 24 black churches in Harlem; 2) a National Institute for Minority Health and Health Disparities P60 project (1P60MD003421, Proj 2) to improve blood pressure control and cancer screening in black barbershops; and 3) a CDC-funded U48 grant (1U48 DP002671) to test the comparative effectiveness of two interventions to increase blood pressure control among black men in New York City.

Dr. Ravenell is a current recipient of the Harold Amos Medical Faculty Development Award from the Robert Wood Johnson Foundation to study a physician-level intervention to improve global cardiovascular risk in black men. He also received the American Heart Association Pharmaceutical Roundtable Career Development Award for Implementation Research for a project focused on improving guideline-concordant hypertension management among physicians within New York City’s municipal health system. He is co-PI of an NIA-funded RC4 grant to examine the impact of a behavioral economics intervention to improve adherence to clinical lipid-lowering guidelines among physicians in a New York City primary care practice. In parallel with developing unique expertise in multi-level cardiovascular and cancer research, Dr. Ravenell has become a leader in hypertension clinical care and training. He is certified as a Specialist in Clinical Hypertension by the American Society of Hypertension, and was elected as an inaugural Fellow of the American Society of Hypertension.

Dr. Ravenell co-founded the Bellevue Hospital Resistant Hypertension Program, and established the first NYU Hypertension and Lipidology Fellowship designed to train physicians in the management of high-risk hypertension and community-based behavioral cardiovascular research. Through research, clinical care and training, Dr. Ravenell continually cultivates a multi-level approach to improving cardiovascular disease and cancer-related population health.